ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	880.98M
Revenue (ttm)	102.97M
Net Income (ttm)	2.19M
Shares Out	51.07M
EPS (ttm)	0.04
PE Ratio	401.91
Forward PE	119.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,239
Average Volume	37,638
Open	16.25
Previous Close	16.30
Day's Range	15.65 - 17.25
52-Week Range	12.34 - 27.00
Beta	0.75
RSI	51.73
Earnings Date	May 8, 2025

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 54
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.